To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa1855
Peptide Name Sequence 1 from Patent US20240309059 A1
Sequence DKEWILQKIYEIMRRLDEEG
Sequence Length 20
Source Synthetic construct
Target Organism SARS-COV-2
Patent Type Patent Application
Publication Date 2024-09-19
Patent No US20240309059 A1
Family Info WO/2023/282281,JPWO2023282281,EP4368631
Patent Title PEPTIDE HAVING ANTI-VIRAL ACTIVITY, ANTI-VIRAL AGENT COMPRISING SAID PEPTIDE, AND METHOD FOR PRODUCING SAID ANTI-VIRAL AGENT
Comment
Abstract Provided is a peptide capable of binding to a receptor binding domain (RBD) in SARS-CoV-2. chemically synthesized easily, having extremely high solubility to ultra-pure water or a buffer solution and a high possibility of being put to practical use as a therapeutic drug for COVID-19.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.